|
Characteristic
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
Hazard ratio (95% CI)
|
P
|
Hazard ratio (95% CI)
|
P
|
|---|
|
Age (<60 vs. ≥60 years)
|
2.43 (1.49–3.96)
|
<0.001
|
1.62 (0.91–2.89)
|
0.100
|
|
Sex (male vs. female)
|
0.61 (0.36–1.05)
|
0.075
| | |
|
Tumor location in the stomach (upper vs. middle vs. lower third)
|
0.59 (0.45–0.77)
|
<0.001
|
0.77 (0.56–1.07)
|
0.119
|
|
Tumor size (<3 vs. ≥3 cm)
|
1.26 (0.78–2.01)
|
0.344
| | |
|
TNM stage (IA vs. IB vs. IIA vs. IIB)
|
1.60 (1.25–2.05)
|
<0.001
|
1.36 (1.01–1.83)
|
0.041
|
|
mGPS (0 vs. 1 vs. 2)
|
1.86 (1.25–2.76)
|
0.002
|
1.24 (0.80–1.93)
|
0.345
|
|
PNI (0 vs. 1)
|
2.36 (1.21–4.62)
|
0.012
|
0.78 (0.31–1.93)
|
0.589
|
|
PLT–NLR (0 vs. 1 vs. 2)
|
1.40 (0.99–1.97)
|
0.057
| | |
|
NLR–PLR (0 vs. 1 vs. 2)
|
2.018 (1.50-2.72)
|
<0.001
|
1.51 (1.02–2.24)
|
0.039
|
-
mGPS modified glasgow prognostic score, PNI prognostic nutritional index, PLT platelet count, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio
